Compass Therapeutics, Inc.

NASDAQ:CMPX

3.12 (USD) • At close February 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q2
Operating Activities:
Net Income -10.479-13.076-10.787-13.415-9.964-11.278-7.837-11.594-11.975-8.494-7.162-12.981-5.977-55.801-7.422-8.391-9.15-5.557-6.402-6.612-8.552-0.009-0.011-0.008
Depreciation & Amortization 0.4650.4660.4630.4680.4660.4750.4810.4840.4870.4980.4350.3960.4060.4090.4131.0690.4350.4370.4630.5210.5390.0010.0010
Deferred Income Tax 000000000000.033-0.03150.618-0.0440.27300.2440.320.0080.012000
Stock Based Compensation 2.1982.1212.0031.61.6251.6281.2671.0251.2871.4441.5741.1860.9870.9080.9481.052.5360.1830.2470.2260.249000
Change In Working Capital -2.9570.462-5.191-0.1952.7370.097-5.5470.055-0.4411.912-2.7896.6951.145-2.080.485-0.592-1.0120.419-2.4150.2431.017-000.001
Accounts Receivables 000000000000000000000000
Change In Inventory 000000000000000000000000
Change In Accounts Payables -0.2320.338-3.2361.7841.582-0.401-2.2570.621-3.6946.199-0.611-0.0010.309-0.50200.238-0.7581.237-0.2850.0020.1770.01100.001
Other Working Capital -2.7250.124-1.955-1.9791.1550.4982.257-0.5663.253-4.287-2.1786.6960.836-1.5780.485-0.83-0.254-0.818-2.130.2410.84-00-0.001
Other Non Cash Items -0.278-0.7275.789-0.06-0.786-1.035-0.593-0.611-0.30.043.0550.0060.0130.0070.0150.0180.022-1.0260.0260.0230.031-0.001-00
Operating Cash Flow -11.051-10.754-13.888-12.354-5.922-10.113-12.229-10.641-10.942-4.6-7.942-4.665-3.457-5.939-5.605-6.573-7.169-5.3-7.761-5.591-6.704-0.009-0.01-0.008
Investing Activities:
Investments In Property Plant And Equipment -0.04400-0.009-0.01-0.0110-0.054-0.027-0.131-0.194-0.777-0.367-0.296-0.128-0.083-0.007-0.004-0.012-0.185-0.0270-00
Acquisitions Net 0000.016-0.0170.00100.37-0.0010.1750.0010.001000.115000000000
Purchases Of Investments -5.347-31.072-41.878-45.079-17.375-38.045-54.919-82.787-11.553-105.77900000000000000
Sales Maturities Of Investments 34.40937.55537.77951.40234.43437.38959.18836.19512.76000000000000000
Other Investing Activites 00-0.0040.0060.017-0.0010.004-0.370.0010.3690.0010.0010-0.3180.1150.08900.055000000
Investing Cash Flow 29.0186.483-4.0996.31417.049-0.6674.269-46.6461.18-105.541-0.193-0.776-0.367-0.614-0.0130.006-0.0070.051-0.012-0.185-0.0270-00
Financing Activities:
Debt Repayment 000000000000000000000000
Common Stock Issued 0017.5690.0010.0213.0310.04176.2320.00500128.26700060.48200000000
Common Stock Repurchased 00-0-000000000000000000000
Dividends Paid 000000000000000000000000
Other Financing Activities -0.0020.001-0.136-0.15900.0030-0.48000-0.28100-1.875-58.607-0.80254.965000000.015
Financing Cash Flow -0.0020.00117.433-0.1580.0213.0310.04175.7520.00500124.236-1.875-1.875-1.875-1.875-2.67753.09000000.015
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000000
Net Change In Cash 17.965-4.27-0.554-6.19811.148-7.749-7.91918.465-9.757-110.141-8.135118.795-5.699-8.428-7.493-8.442-9.85347.841-7.773-5.776-6.731-0.009-0.0110.007
Cash At End Of Period 37.36919.40423.67424.22830.42619.27827.02734.94616.48126.238136.379144.51425.71931.41839.84647.33955.78165.63417.79325.56631.3420.0380.0470.007